Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07096726 · ClinicalTrials.gov registry record · NA
Boston Medical Center Ultrasound Decongestion Study in Heart Failure
A NA study, sponsored by Boston Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT07096726 is a NA study that has not yet begun recruiting, run by Boston Medical Center. The registered enrollment target is 200 participants.
The verdict
NCT07096726, a NA study, has not yet begun recruiting, sponsored by Boston Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to analyze the utility of a novel five-point ultrasound as a predictor of volume overload in diverse patients who are admitted with volume overload/congestive heart failure (CHF) exacerbation at Boston Medical Center (BMC), the largest safety-net hospital in New England. Current standard of care (SOC) involves the utilization of laboratory markers and physical exam, which is often inconsistent and equivocal. The investigators will assess will assess if ultrasound-assisted diuresis reduces recurrent episodes of volume overload/decompensated heart failure.
Interventions
- OTHER Standard of care
- DEVICE Five-point ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-09 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07096726
The ClinicalTrials.gov registry entry for NCT07096726 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of care is the first listed.
NCT07096726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07096726 about?
NCT07096726 is a clinical study titled "Boston Medical Center Ultrasound Decongestion Study in Heart Failure". The purpose of this study is to analyze the utility of a novel five-point ultrasound as a predictor of volume overload in diverse patients who are admitted with volume overload/congestive heart failure (CHF) exacerbation at Boston Medical Center (BMC), the largest safety-net hospital in New England....
What is the current status of trial NCT07096726?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-09. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07096726?
The interventions under investigation include: Standard of care (OTHER), Five-point ultrasound (DEVICE).
Who is sponsoring clinical trial NCT07096726?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.